Exhaled breath condensate: Determination of non-volatile compounds and their potential for clinical diagnosis and monitoring. A review |
| |
Authors: | Petr Kubá ň,Franti&scaron ek ForetAuthor Vitae |
| |
Affiliation: | Bioanalytical Instrumentation, CEITEC - Central European Institute of Technology, Masaryk University, Veveri 97, 602 00 Brno, Czech Republic |
| |
Abstract: | Exhaled breath condensate is a promising, non-invasive, diagnostic sample obtained by condensation of exhaled breath. Starting from a historical perspective of early attempts of breath testing towards the contemporary state-of-the-art breath analysis, this review article focuses mainly on the progress in determination of non-volatile compounds in exhaled breath condensate. The mechanisms by which the aerosols/droplets of non-volatile compounds are formed in the airways are discussed with methodological consequences for sampling. Dilution of respiratory droplets is a major problem for correct clinical interpretation of the measured data and there is an urgent need for standardization of EBC. This applies also for collection instrumentation and therefore various commercial and in-house built devices are described and compared with regard to their design, function and collection parameters. The analytical techniques and methods for determination of non-volatile compounds as potential markers of oxidative stress and lung inflammation are scrutinized with an emphasis on method suitability, sensitivity and appropriateness. The relevance of clinical findings for each group of possible non-volatile markers of selected pulmonary diseases and methodological recommendations with emphasis on interdisciplinary collaboration that is essential for future development into a fully validated clinical diagnostic tool are given. |
| |
Keywords: | 3-NT, 3-nitrotyrosine 5-HPETE, 5-hydroperoxyeicosatetraenoic acid 5-LO, 5-lipoxygenase 8-IP, 8-isoprostane ALF, airway lining fluid BAL, bronchoalveolar lavage CF, cystic fibrosis COPD, chronic obstructive pulmonary disease COX, cyclooxygenase EBC, exhaled breath condensate FDA, U.S. Food and Drug Administration GSH, glutathione GSSG, glutathione disulfide INF-γ, interferon γ LT, leukotriene NMR, nuclear magentic resonance PCA, principal component analysis PLS, partial least squares PLS-DA, partial least squares discriminant analysis PP, polypropylene PE, polyethylene PG, prostaglandin PTFE, polytetrafluoroethylene ROS, reactive oxygen species RS&ndash NO, S-nitrosothiols SI, sputum induction VOC, volatile organic compounds TNF-α, tumor necrosis factor α |
本文献已被 ScienceDirect 等数据库收录! |
|